Predictive performance of HAS-BLED, ORBIT, ABC, and DOAC scores for major bleeding in atrial fibrillation patients on DOACs

MeSH terms

• Aged
• Aged, 80 and over
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use
• Atrial Fibrillation* / complications
• Atrial Fibrillation* / drug therapy
• Factor Xa Inhibitors* / adverse effects
• Factor Xa Inhibitors* / therapeutic use
• Female
• Hemorrhage* / chemically induced
• Humans
• Male
• Middle Aged
• Predictive Value of Tests
• Risk Assessment
• Stroke